Drug-Drug Interaction - 3 Arm - Carboplatin/Paclitaxel, Dacarbazine

NCT00796991 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Melanoma

Interventions

DRUG: Ipilimumab
DRUG: Carboplatin
DRUG: Paclitaxel
DRUG: Dacarbazine

Sponsor

Bristol-Myers Squibb

Collaborators

[object Object]